Recent developments in health news include GSK's mixed results in cancer treatment trials, Novo Nordisk's market plunge ...
Passed peacefully at home on 9th December 2024, aged 72. Now reunited with her beloved husband, John Clutterbuck. A cherished ...
His mother was a teacher. Chris grew up with a strong sense of social justice, an attribute that his children inherited and ...
The latest updates in the health sector involve significant trials and approvals. GSK's ovarian cancer drug trial met its ...
Here’s a look at some of the standout residential light displays giving back to the community across Northeast Ohio.
Four women from Pembrokeshire are planning to row the Atlantic in January for causes very close to their hearts and could ...
The Food and Drug Administration signed off on Vertex Pharmaceuticals' next-generation triple drug for cystic fibrosis late ...
The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' next-generation treatment for a rare and ...
Vertex Pharmaceuticals (VRTX) said Friday the U.S. Food and Drug Administration expanded its approval of a cystic fibrosis treatment, ...
(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) Friday announced that the U.S. Food and Drug Administration (FDA) has approved Alyftrek for treatment of cystic fibrosis.
The U.S. Food and Drug Administration (FDA) today approved the expansion of Trikafta (elexacaftor/tezacaftor/ivacaftor) to ...
Vertex Pharmaceuticals said Friday the U.S. Food and Drug Administration expanded its approval of a cystic fibrosis treatment, encompassing more patients with different types of mutations of the ...